Quest Diagnostics to acquire select laboratory assets from Fresenius Medical Care.

Quest Diagnostics, a provider of diagnostic information services, agreed to acquire select laboratory assets from Fresenius Medical Care, a provider of products and services for individuals with renal disease. "Our relationship with Fresenius Medical Care will extend our industry-leading test portfolio in chronic kidney disease, one of the nation's most prevalent chronic diseases, to include dialysis-related laboratory and water testing. It will also optimize Quest's national scale to bring high-quality laboratory services closer to FME's dialysis clinics and the patients under their care across the United States," Jim Davis, Quest Diagnostics Chairman, CEO and President.